L

Lexicon Pharmaceuticals
D

LXRX

0.67820
USD
-0.02
(-2.39%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
246,307,320
أصول ذات صلة
ABBV
ABBV
-1.290
(-0.67%)
191.070 USD
AMGN
AMGN
-2.10
(-0.70%)
295.22 USD
BMY
BMY
-0.910
(-1.80%)
49.760 USD
GSK
GSK
-1.630
(-3.84%)
40.840 USD
JNJ
JNJ
0.425
(0.27%)
157.090 USD
LLY
LLY
7.54
(0.93%)
819.54 USD
MRK
MRK
-0.050
(-0.06%)
81.740 USD
NVO
NVO
-1.210
(-1.49%)
79.850 USD
PFE
PFE
-0.315
(-1.27%)
24.535 USD
REGN
REGN
7.50
(1.44%)
529.39 USD
المزيد
الأخبار المقالات

العنوان: Lexicon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.